How Patient Journey Analytics Contribute to Better Outcomes
- A complete view:
Unlike business intelligence (BI) dashboards limited in the number of data sources and the data volume they can analyze, WhizAI is highly scalable. It can analyze billions of data points, from healthcare provider (HCP) referral patterns, NBRx, and optimal dosage and titration data to patient outcomes. Better yet, WhizAI can deliver the answer a patient services team needs in less than a second, regardless of how complex the question or how much data is required for a complete picture of a patient’s circumstances.
- Accessible, actionable insights:
Few patient services team members are also data scientists. WhizAI understands that the people on your team need patient experience analytics insights to do their jobs effectively, regardless of data analytics or IT expertise. With our platform, users simply ask a question, and WhizAI, powered by artificial intelligence (AI), machine learning (ML), and natural language processing (NLP), responds. Users don’t have to memorize keywords or particular phrases to use the platform. WhizAI understands the way patient services professionals communicate.
- Automated visualizations:
Life science company teams have busy schedules and juggle a variety of tasks. WhizAI automatically creates visualizations based on the information it’s presenting and user preferences. With WhizAI, users always have the most important information front and center and insights that lead to quick decisions on the best next steps.
- Invisible technology:
WhizAI believes that your team deserves powerful patient experience analytics capabilities – but that they should never even realize they’re using a BI solution. Instead, we’ve designed our platform to be as easy to use as a social media app, moving technology to the background and making seamless user experiences the priority.
Case Study: WhizAI Helps Manage 20,000+ Patients and Keep Them On Track With Their Therapies
A top global pharmaceutical company with 50 products across 10 therapeutic areas serves more than 20,000 patients. The company created a comprehensive patient portal to enhance patient experiences. However, 25% of patients discontinued using the portal within 90 days, and 20% of patients never began their therapy. The pharma company identified the root cause of the issue as a lack of visibility into the patient landscape. The thorough analysis required using a range of data sources and quickly delivering the insights that patients needed.
The company deployed WhizAI for patient experience analytics and, in only six weeks, saw 100% adoption of the solution, greater visibility into each phase of the patient journey, and instant identification of patients at high risk of discontinuation. With WhizAI, the company improved adherence and reduced dependency on its IT department by 60%, saw a 50% reduction in analytics total cost of ownership (TCO), and a five-fold increase in productivity.
The Benefits of Patient Service Analytics
WhizAI is pretrained for life sciences, enabling deployment within weeks rather than the months it would take to train a generic AI solution for the industry. Also, once deployed, users need only a few minutes to familiarize themselves with the platform before they can begin getting the patient experience analytics insights that help them do their jobs successfully.
Identifying outliers, patients at risk for discontinuing their medications, or spotting unanticipated changes are key to patient services. But monitoring data manually is impossible, particularly at the speed of business. WhizAI identifies anomalies in patient data from end-user medical devices such as glucose monitors and ECGs, prescription adherence, and patient histories, and alerts patient services teams.
With technology that delivers patient experience analytics insights to users on-demand or proactively – employees have more time to focus on their core responsibilities rather than on using a BI solution. WhizAI’s ease of use also decreases reliance on a life science company’s IT and data teams, allowing resources to use their talents to help the company develop a stronger competitive position.
A Culture of Data
When patient services teams realize how easy WhizAI makes building data into daily workflows – and how outcomes improve – they’ll begin to make data-driven decision making standard practice and enjoy greater success in their jobs
Adding Up Data Analytics Total Cost of Ownership (TCO) and How to Lower It
High data analytics expenditures don’t have to be a cost of doing business for life sciences companies. WhizAI lowers total cost of ownership (TCO) while making data insights more accessible to business users. Traditionally, data analytics TCO has been a significant expense for life sciences organizations.
Gartner® Predicts Augmented Analytics Will Have a Major Impact on Life Sciences Commercial Functions
Gartner recognizes WhizAI as a Sample Vendor for Augmented Analytics, an emerging technology poised to revolutionize how commercial teams use data insights to optimize outcomes.
Transforming Life Sciences Commercial Function with AI and Augmented Analytics
In this whitepaper, sponsored by WhizAl, Everest Group explores the business case and profound impact Al and Augmented Analytics can have on the life sciences commercial function across various use cases in Sales, Marketing, and Market Access. They examine what top pharma enterprises are looking for in an augmented analytics tool, a roadmap for how to get started, and a blueprint for adoption.
WhizAI Deployed as a New Field Reporting System at a Top 3 Global Pharma
Better, Faster, Smarter Decisions at Lower Cost for a Top 3 Global Pharma. A top 3 global pharmaceutical faced the following challenges with their legacy field reporting system:
WhizAI Puts Sales Reps at the Center of the Analytics Process for a Leading Specialty Pharmaceutical Company
Sales reps use WhizAI data exploration to answer questions like 'Sales trends this year by region, brand (or by city, territory, GPO, COT, IDN)?' in seconds.